Term Name:	EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor
Synonyms:	(5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitor, (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitors, (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprost-5,13-dienoate:NAD(+) 15-oxidoreductase inhibitor, (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprost-5,13-dienoate:NAD(+) 15-oxidoreductase inhibitors, 11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitor, 11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitors, 15-hydroxyprostaglandin dehydrogenase (NAD(+)) (EC 1.1.1.141) inhibitor, 15-hydroxyprostaglandin dehydrogenase (NAD(+)) (EC 1.1.1.141) inhibitors, 15-hydroxyprostaglandin dehydrogenase (NAD(+)) inhibitor, 15-hydroxyprostaglandin dehydrogenase (NAD(+)) inhibitors, 15-hydroxyprostaglandin dehydrogenase inhibitor, 15-hydroxyprostaglandin dehydrogenase inhibitors, 15-hydroxyprostanoic dehydrogenase inhibitor, 15-hydroxyprostanoic dehydrogenase inhibitors, 15-OH-PGDH inhibitor, 15-OH-PGDH inhibitors, EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitors, EC 1.1.1.141 inhibitor, EC 1.1.1.141 inhibitors, NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase (type I) inhibitor, NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase (type I) inhibitors, NAD-specific 15-hydroxyprostaglandin dehydrogenase inhibitor, NAD-specific 15-hydroxyprostaglandin dehydrogenase inhibitors, PGDH inhibitor, PGDH inhibitors, prostaglandin dehydrogenase inhibitor, prostaglandin dehydrogenase inhibitors
Definition:	An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of 15-hydroxyprostaglandin dehydrogenase (NAD(+)) (EC 1.1.1.141).
Ontology:	ChEBI [CHEBI:77108]  ( EBI )